subscribeSubscribe
Baxter`s Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.

Baxter`s Generic Regadenoson Monohydrate Receives Receives Approval in the U.S.
FDA
23 May 2023
Share Share
Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal

Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal
PRESS RELEASE
12 May 2023
Share Share
Dr Reddy`s Laboratories launches Regadenoson injection in US market

Dr Reddy`s Laboratories launches Regadenoson injection in US market
ECONOMICTIMES
05 May 2023
Share Share
Mylan`s Generic Regadenoson MonohydrateReceives Approval in the U.S.

Mylan`s Generic Regadenoson MonohydrateReceives Approval in the U.S.
FDA
04 Apr 2023
Share Share
Hikma`s Generic Regadenoson Receives Approval in the U.S.

Hikma`s Generic Regadenoson Receives Approval in the U.S.
FDA
02 Feb 2023
Share Share
Appeals court sides with Pfizer in patent fight with Astellas

Appeals court sides with Pfizer in patent fight with Astellas
Kevin Dunleavy FIERCE PHARMA
05 Jan 2023
Share Share
Eugia`s Generic Regadenoson Monohydrate Receives Approval in the U.S.

Eugia`s Generic Regadenoson Monohydrate Receives Approval in the U.S.
FDA
26 Oct 2022
Share Share
Hospira must wait to launch generic Lexiscan—but only two weeks

Hospira must wait to launch generic Lexiscan—but only two weeks
Kevin Dunleavy FIERCEPHARMA
27 Sep 2022
Share Share
Hospira`s Generic Regadenoson Receives Approval in the U.S.

Hospira`s Generic Regadenoson Receives Approval in the U.S.
FDA
31 Aug 2022
Share Share
Delaware court rules against Gilead and Astellas in years-long patent case

Delaware court rules against Gilead and Astellas in years-long patent case
Tyler Patchen ENDPTS
23 May 2022
Share Share